MAHAK Participates in Cell Therapy Scientific Meeting 2026

MAHAK participated in the Cell Therapy Scientific Meeting 2026, held at the Parsian Exhibition Center in Tehran, as part of the organization’s ongoing efforts to strengthen its Hematopoietic Stem Cell Transplantation (HSCT) twinning program and expand scientific collaboration in advanced cancer treatment.

This scientific meeting brought together experts in cell therapy and transplantation to exchange knowledge, discuss recent scientific developments, and explore opportunities for collaboration.

Among MAHAK’s representatives, Dr. Vahid Falahati, an oncology and HSCT specialist, delivered a presentation titled “Cellular Rescue: CD34 Boost, DLI, and Virus-Specific T Cells,” focusing on advanced cellular approaches in the post-transplant setting.

Other members of MAHAK’s multidisciplinary team also participated in the meeting, including Dr. Hadieh Eslampanah, medical biotechnologist in the field of cancer and Director of MAHAK’s Public Relations and International Communications Department; Dr. Ali Naderi,  pediatric hematologist-oncologist and BMT specialist and at MAHAK; and Dr. Hadi Mousakhani, an oncologist and Head of MAHAK’s Oncology Department.

Bringing together expertise in HSCT, oncology, and medical biotechnology, MAHAK’s team reflects the multidisciplinary approach required for the development of advanced treatment strategies and specialized care for children with cancer.

MAHAK’s presence at the Cell Therapy Scientific Meeting 2026 marked another step in the development of its HSCT twinning program and its broader commitment to knowledge-based, multidisciplinary, and innovative approaches in cancer care